Cite
HARVARD Citation
Nettekoven, M. et al. (2016). Inside Cover: Novel Triazolopyrimidine‐Derived Cannabinoid Receptor 2 Agonists as Potential Treatment for Inflammatory Kidney Diseases (ChemMedChem 2/2016). ChemMedChem. 11 (2), p. 147. [Online].